ArticleJournal of cancer research and clinical oncology2019

Co-targeting PI3K/Akt and MAPK/ERK pathways leads to an enhanced antitumor effect on human hypopharyngeal squamous cell carcinoma.

Xiaolin Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.